Cargando…

Outcomes of Hydroxyurea Accessed via Various Means and Barriers Affecting Its Usage Among Children with Sickle Cell Anaemia in North-Western Tanzania

PURPOSE: To assess clinical and haematological outcomes of Hydroxyurea accessed via various access means and uncover the barriers to its utilization in children with Sickle cell anaemia (SCA), North-western Tanzania. PATIENTS AND METHODS: A retrospective study was conducted between October 2020 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrose, Emmanuela E, Kidenya, Benson R, Charles, Mwesige, Ndunguru, Joyce, Jonathan, Agnes, Makani, Julie, Minja, Irene K, Ruggajo, Paschal, Balandya, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875573/ https://www.ncbi.nlm.nih.gov/pubmed/36712580 http://dx.doi.org/10.2147/JBM.S380901

Ejemplares similares

Healthcare Workers’ Knowledge and Resource Availability for Care of Sickle Cell Disease in Dar es Salaam, Tanzania
por: Jonathan, Agnes, et al.
Publicado: (2022)

Prevalence of Hemoglobin-S and Baseline Level of Knowledge on Sickle Cell Disease Among Pregnant Women Attending Antenatal Clinics in Dar-Es-Salaam, Tanzania
por: Tutuba, Hilda J., et al.
Publicado: (2022)

Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators
por: Mlyuka, Hamu J., et al.
Publicado: (2022)

The efficacy of maternal health education and maternal screening on knowledge and the uptake of infant screening for sickle cell disease in Dar-Es-Salaam, Tanzania; a quasi experimental study
por: Tutuba, Hilda J., et al.
Publicado: (2023)

Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania
por: Mutagonda, Ritah F, et al.
Publicado: (2022)

P108: ASSESSMENT OF HEALTHCARE WORKERS’ KNOWLEDGE AND RESOURCE AVAILABILITY FOR CARE OF SICKLE CELL DISEASE AT HEALTH FACILITIES IN DAR ES SALAAM, TANZANIA
por: Jonathan, A, et al.
Publicado: (2022)

Oxygen Saturation in Primary Teeth of Individuals With Sickle Cell Disease and Sickle Cell Trait
por: Wilson, Evarist Mulyahela, et al.
Publicado: (2022)

The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experiences of Parents in Tanzania
por: Kilonzi, Manase, et al.
Publicado: (2022)

Health Related Quality of Life among Children with Sickle Cell Anaemia in Northwestern Tanzania
por: Mwazyunga, Zivonishe, et al.
Publicado: (2022)

5610785 THE EFFICACY OF HEALTH EDUCATION INTERVENTION AND MATERNAL SCREENING ON KNOWLEDGE AND INFANT SCREENING FOR SICKLE CELL DISEASE AMONG PREGNANT WOMEN ATTENDING ANTENATAL CLINICS IN DAR-ES-SALAAM, TANZANIA
por: Tutuba, H.J., et al.
Publicado: (2023)

Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine
por: Kilonzi, Manase, et al.
Publicado: (2022)

Prevalence and factors associated with severe anaemia amongst under-five children hospitalized at Bugando Medical Centre, Mwanza, Tanzania
por: Simbauranga, Rehema H., et al.
Publicado: (2015)

Surveillance for sickle cell disease, United Republic of Tanzania
por: Ambrose, Emmanuela E, et al.
Publicado: (2020)

Bacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in Tanzania
por: Makani, Julie, et al.
Publicado: (2015)

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings
por: Smart, Luke R., et al.
Publicado: (2023)

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost
por: Costa, Enrico, et al.
Publicado: (2020)

Hydroxyurea usage awareness among patients with sickle‐cell disease in Saudi Arabia
por: Alsalman, Mortadah, et al.
Publicado: (2021)

Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria
por: Ofakunrin, Akinyemi O D, et al.
Publicado: (2019)

Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients
por: Kargutkar, Neha, et al.
Publicado: (2023)

Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises
por: Soren, Uttam Kumar, et al.
Publicado: (2022)

Building sustainable research capacity at higher learning institutions in Tanzania through mentoring of the Young Research Peers
por: Balandya, Emmanuel, et al.
Publicado: (2021)

The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania
por: Sawe, Hendry R., et al.
Publicado: (2018)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania
por: Makubi, Abel, et al.
Publicado: (2016)

P102: PLASMA FREE HEMOGLOBIN AND REACTIVE OXYGEN SPECIES IN SICKLE CELL ANAEMIA PATIENTS UNDER HYDROXYUREA AND GLUTAMINE THERAPY
por: Giannaki, A, et al.
Publicado: (2022)

Building research capacity for sickle cell disease in Africa: Lessons and challenges from establishing a birth cohort in Tanzania
por: Nkya, Siana, et al.
Publicado: (2022)

Prevalence and risk factors of acute kidney injury in polytrauma patients at Muhimbili Orthopedic Institute, Tanzania
por: Muhamedhussein, Mohamed S., et al.
Publicado: (2021)

Haptoglobin, alpha‐thalassaemia and glucose‐6‐phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania
por: Cox, Sharon E., et al.
Publicado: (2014)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

Renal Dysfunction among HIV-Infected Patients on Antiretroviral Therapy in Dar es Salaam, Tanzania: A Cross-Sectional Study
por: Mwemezi, Oswin, et al.
Publicado: (2020)

Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania
por: Malindisa, Evangelista, et al.
Publicado: (2023)

Prevalence and predictors of heart failure among patients on maintenance hemodialysis therapy at Muhimbili National Hospital in Tanzania: a cross-sectional study
por: Bramania, Puneet Kishore, et al.
Publicado: (2021)

Prevalence and risk factors for red blood cell alloimmunisation among sickle cell patients in Mwanza City, Tanzania
por: Tebuka, Erius, et al.
Publicado: (2020)

Nutritional Status of Patients on Maintenance Hemodialysis at Muhimbili National Hospital in Dar es Salaam, Tanzania: A Cross-Sectional Study
por: Bramania, Puneet, et al.
Publicado: (2021)

Renal abnormalities among HIV infected children at Muhimbili National Hospital (MNH)—Dar es Salaam, Tanzania
por: Fredrick, Francis, et al.
Publicado: (2016)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2ld8f1uilr79qfc5p7grem1q98